While significant improvements have been made for children with acute lymphoblastic leukemia (ALL) in the U.S., Black patients continue to have inferior outcomes.

Join us for an informative panel discussion and Q & A session about the importance of equal access to effective treatments and the potential impact on cure and mortality rates.

REGISTRATION LINK: https://bit.ly/NCBW-LLS-4